Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
24 November 2016
Header
Header image
News

News

EFPIA opinion on the Annual Growth Survey and recommendations for the European Semester 2017
23 November 2016

EFPIA welcomes the publication by the European Commission of the Annual Growth Survey, starting off the European Semester Cycle for 2017. EFPIA agrees with the three [...] Read more

From our blog

From our blog

Barriers to Integrated Care and How to Overcome Them
24 November 2016 by Thomas Allvin

Around 75% of healthcare spending in Europe is directed towards managing and treating chronic diseases. Looking at different patient groups, around 10% of patients account for almost two-thirds of healthcare expenditure. These patients are to a large extent elderly people with multiple chronic conditions. The figures show clearly why increased effectiveness in preventing, managing and treating chronic diseases is a matter of the highest priority for most health policy makers – and finance ministers.

Read more

From our blog

Health Collaboration Awards 2016: Together for Better Health, for us-by us
24 November 2016 by

The EFPIA Patient Think Tank established the Health Collaboration Awards in 2015, to share best practice in collaborative projects that address healthcare needs. Entrants include collaborations between patient organisations, industry, local authorities, healthcare systems and other key actors in delivering healthcare.

Read more

From our blog

Refocusing, Revitalising and Reinforcing Our Commitment to Tackling AMR
24 November 2016 by Elizabeth Kuiper

Nobody can say that the pharmaceutical industry has been idle over the course of 2016 in its pursuit for an effective solution to combat the rise of growing antimicrobial resistance. We’ve made significant progress in launching and developing a collaborative approach towards fighting this threat and in raising awareness about AMR in Europe and globally, maintaining the momentum for political action.

Read more

Videos

Video

Refocusing, Revitalising and Reinforcing Our Commitment to Tackling AMR

View video

Events calendar

Events Calendar

Optimising the Development of ATMPs to Meet Patient Needs - The fifth annual regulatory conference organised by the European Biopharmaceutical Enterprises (EBE) in collaboration with the European Medicines Agency (EMA)
On 16/12/2016 (London, UK)

Europe is a world-leader in the development of cutting edge Advanced Therapies Medicinal Products (ATMPs) including gene therapies. This conference, organised in collaboration with the EMA, will feature a gathering of international thought-leaders who will highlight initiatives to improve the access to ATMPs for patients, as well as outline the needs for their development and commercialisation within the EU.

For more information on the programme and to register, click here.

Read more

Events Calendar

War on Cancer 2016
On 06/12/2016 (London, UK)

Join over 150 global leaders in oncology at The Economist Events' second annual War on Cancer conference, on December 6th in London. Explore solutions to the mismatch in progress and delivery in cancer care across Europe. The event will seek to find answers to questions such as: Should tobacco taxes be used to fund cancer care? Why do some European nations with similar health care systems have such striking differences in cancer survival rates? What is the true potential of immuno-therapy? What were the key learnings from the 2016 World Cancer Congress?
Contributing to this discussion will be speakers from the UK Government, Public Health England, the European Commission, the University of Oxford, Macmillan Cancer Support, European Medicines Agency, the Institute of Cancer Policy and the Institute of Cancer Research London. Plus, hear from the chief executive of Philips and senior business figures at Pfizer and EMD Serono.

Read more

Events Calendar

Patients as Partners Europe
From 06/02/2017 to 07/02/2017 (London, UK)

Patients as Partners Europe is the only conference putting the patient voice on the same level as industry and government in finding solutions to engage and empower patients in the clinical development and trial process. Join clinical trial leaders from Pharma, Patient Advocacy and Goverment. The programme is co-located with DPharm Europe. 

Read more

What we are reading

What we are reading

IMI Newsletter
24 November 2016 (IMI)

Read here the lastest issue of the IMI newsletter, with updates on events and interesting success stories from the IMI projects.

Read more

What we are reading

Health at a Glance: Europe
24 November 2016 (European Commission)

The Health at a Glance: Europe series gauges progress towards effective, accessible and resilient health systems. The report provides a neutral, descriptive comparison on the basis of transparent indicators.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail